Global Flu (Influenza) Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 102

Published Date: 08 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

According to our (Global Info Research) latest study, the global Flu (Influenza) Vaccine market size was valued at USD 5664.4 million in 2022 and is forecast to a readjusted size of USD 7180 million by 2029 with a CAGR of 3.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).

This report is a detailed and comprehensive analysis for global Flu (Influenza) Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Flu (Influenza) Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Flu (Influenza) Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Flu (Influenza) Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Flu (Influenza) Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Flu (Influenza) Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Flu (Influenza) Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hualan Bio, CCBIO, Aleph Biomedical, SANOFI and Adimmune, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Flu (Influenza) Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Split Influenza Vaccine
    Pandemic Influenza Vaccine
    Subunit Influenza Vaccine
    Quadrivalent Influenza Vaccine

Market segment by Application
    For Children (6 months to 3 years)
    For Adults and Children over 3 years

Major players covered
    Hualan Bio
    CCBIO
    Aleph Biomedical
    SANOFI
    Adimmune
    ZYAK
    SINOVAC
    Changsheng Biological
    SIOBP
    GSK
    Aimei Hissen
    Tianyuan Bio-pharma(Novartis)
    Simcere Vaxtec

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flu (Influenza) Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Flu (Influenza) Vaccine, with price, sales, revenue and global market share of Flu (Influenza) Vaccine from 2018 to 2023.
Chapter 3, the Flu (Influenza) Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu (Influenza) Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Flu (Influenza) Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Flu (Influenza) Vaccine.
Chapter 14 and 15, to describe Flu (Influenza) Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Flu (Influenza) Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Flu (Influenza) Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Split Influenza Vaccine
        1.3.3 Pandemic Influenza Vaccine
        1.3.4 Subunit Influenza Vaccine
        1.3.5 Quadrivalent Influenza Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Flu (Influenza) Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 For Children (6 months to 3 years)
        1.4.3 For Adults and Children over 3 years
    1.5 Global Flu (Influenza) Vaccine Market Size & Forecast
        1.5.1 Global Flu (Influenza) Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Flu (Influenza) Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Flu (Influenza) Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Hualan Bio
        2.1.1 Hualan Bio Details
        2.1.2 Hualan Bio Major Business
        2.1.3 Hualan Bio Flu (Influenza) Vaccine Product and Services
        2.1.4 Hualan Bio Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Hualan Bio Recent Developments/Updates
    2.2 CCBIO
        2.2.1 CCBIO Details
        2.2.2 CCBIO Major Business
        2.2.3 CCBIO Flu (Influenza) Vaccine Product and Services
        2.2.4 CCBIO Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 CCBIO Recent Developments/Updates
    2.3 Aleph Biomedical
        2.3.1 Aleph Biomedical Details
        2.3.2 Aleph Biomedical Major Business
        2.3.3 Aleph Biomedical Flu (Influenza) Vaccine Product and Services
        2.3.4 Aleph Biomedical Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Aleph Biomedical Recent Developments/Updates
    2.4 SANOFI
        2.4.1 SANOFI Details
        2.4.2 SANOFI Major Business
        2.4.3 SANOFI Flu (Influenza) Vaccine Product and Services
        2.4.4 SANOFI Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 SANOFI Recent Developments/Updates
    2.5 Adimmune
        2.5.1 Adimmune Details
        2.5.2 Adimmune Major Business
        2.5.3 Adimmune Flu (Influenza) Vaccine Product and Services
        2.5.4 Adimmune Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Adimmune Recent Developments/Updates
    2.6 ZYAK
        2.6.1 ZYAK Details
        2.6.2 ZYAK Major Business
        2.6.3 ZYAK Flu (Influenza) Vaccine Product and Services
        2.6.4 ZYAK Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 ZYAK Recent Developments/Updates
    2.7 SINOVAC
        2.7.1 SINOVAC Details
        2.7.2 SINOVAC Major Business
        2.7.3 SINOVAC Flu (Influenza) Vaccine Product and Services
        2.7.4 SINOVAC Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 SINOVAC Recent Developments/Updates
    2.8 Changsheng Biological
        2.8.1 Changsheng Biological Details
        2.8.2 Changsheng Biological Major Business
        2.8.3 Changsheng Biological Flu (Influenza) Vaccine Product and Services
        2.8.4 Changsheng Biological Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Changsheng Biological Recent Developments/Updates
    2.9 SIOBP
        2.9.1 SIOBP Details
        2.9.2 SIOBP Major Business
        2.9.3 SIOBP Flu (Influenza) Vaccine Product and Services
        2.9.4 SIOBP Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 SIOBP Recent Developments/Updates
    2.10 GSK
        2.10.1 GSK Details
        2.10.2 GSK Major Business
        2.10.3 GSK Flu (Influenza) Vaccine Product and Services
        2.10.4 GSK Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 GSK Recent Developments/Updates
    2.11 Aimei Hissen
        2.11.1 Aimei Hissen Details
        2.11.2 Aimei Hissen Major Business
        2.11.3 Aimei Hissen Flu (Influenza) Vaccine Product and Services
        2.11.4 Aimei Hissen Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Aimei Hissen Recent Developments/Updates
    2.12 Tianyuan Bio-pharma(Novartis)
        2.12.1 Tianyuan Bio-pharma(Novartis) Details
        2.12.2 Tianyuan Bio-pharma(Novartis) Major Business
        2.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product and Services
        2.12.4 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Tianyuan Bio-pharma(Novartis) Recent Developments/Updates
    2.13 Simcere Vaxtec
        2.13.1 Simcere Vaxtec Details
        2.13.2 Simcere Vaxtec Major Business
        2.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Product and Services
        2.13.4 Simcere Vaxtec Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Simcere Vaxtec Recent Developments/Updates

3 Competitive Environment: Flu (Influenza) Vaccine by Manufacturer
    3.1 Global Flu (Influenza) Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Flu (Influenza) Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Flu (Influenza) Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Flu (Influenza) Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Flu (Influenza) Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Flu (Influenza) Vaccine Manufacturer Market Share in 2022
    3.5 Flu (Influenza) Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Flu (Influenza) Vaccine Market: Region Footprint
        3.5.2 Flu (Influenza) Vaccine Market: Company Product Type Footprint
        3.5.3 Flu (Influenza) Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Flu (Influenza) Vaccine Market Size by Region
        4.1.1 Global Flu (Influenza) Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Flu (Influenza) Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Flu (Influenza) Vaccine Average Price by Region (2018-2029)
    4.2 North America Flu (Influenza) Vaccine Consumption Value (2018-2029)
    4.3 Europe Flu (Influenza) Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Flu (Influenza) Vaccine Consumption Value (2018-2029)
    4.5 South America Flu (Influenza) Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Flu (Influenza) Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Flu (Influenza) Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Flu (Influenza) Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Flu (Influenza) Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Flu (Influenza) Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global Flu (Influenza) Vaccine Consumption Value by Application (2018-2029)
    6.3 Global Flu (Influenza) Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America Flu (Influenza) Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Flu (Influenza) Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America Flu (Influenza) Vaccine Market Size by Country
        7.3.1 North America Flu (Influenza) Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Flu (Influenza) Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Flu (Influenza) Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Flu (Influenza) Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe Flu (Influenza) Vaccine Market Size by Country
        8.3.1 Europe Flu (Influenza) Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Flu (Influenza) Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Flu (Influenza) Vaccine Market Size by Region
        9.3.1 Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Flu (Influenza) Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Flu (Influenza) Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Flu (Influenza) Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America Flu (Influenza) Vaccine Market Size by Country
        10.3.1 South America Flu (Influenza) Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Flu (Influenza) Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Flu (Influenza) Vaccine Market Size by Country
        11.3.1 Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Flu (Influenza) Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Flu (Influenza) Vaccine Market Drivers
    12.2 Flu (Influenza) Vaccine Market Restraints
    12.3 Flu (Influenza) Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Flu (Influenza) Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Flu (Influenza) Vaccine
    13.3 Flu (Influenza) Vaccine Production Process
    13.4 Flu (Influenza) Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Flu (Influenza) Vaccine Typical Distributors
    14.3 Flu (Influenza) Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Flu (Influenza) Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Flu (Influenza) Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 4. Hualan Bio Major Business
    Table 5. Hualan Bio Flu (Influenza) Vaccine Product and Services
    Table 6. Hualan Bio Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Hualan Bio Recent Developments/Updates
    Table 8. CCBIO Basic Information, Manufacturing Base and Competitors
    Table 9. CCBIO Major Business
    Table 10. CCBIO Flu (Influenza) Vaccine Product and Services
    Table 11. CCBIO Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. CCBIO Recent Developments/Updates
    Table 13. Aleph Biomedical Basic Information, Manufacturing Base and Competitors
    Table 14. Aleph Biomedical Major Business
    Table 15. Aleph Biomedical Flu (Influenza) Vaccine Product and Services
    Table 16. Aleph Biomedical Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Aleph Biomedical Recent Developments/Updates
    Table 18. SANOFI Basic Information, Manufacturing Base and Competitors
    Table 19. SANOFI Major Business
    Table 20. SANOFI Flu (Influenza) Vaccine Product and Services
    Table 21. SANOFI Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. SANOFI Recent Developments/Updates
    Table 23. Adimmune Basic Information, Manufacturing Base and Competitors
    Table 24. Adimmune Major Business
    Table 25. Adimmune Flu (Influenza) Vaccine Product and Services
    Table 26. Adimmune Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Adimmune Recent Developments/Updates
    Table 28. ZYAK Basic Information, Manufacturing Base and Competitors
    Table 29. ZYAK Major Business
    Table 30. ZYAK Flu (Influenza) Vaccine Product and Services
    Table 31. ZYAK Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. ZYAK Recent Developments/Updates
    Table 33. SINOVAC Basic Information, Manufacturing Base and Competitors
    Table 34. SINOVAC Major Business
    Table 35. SINOVAC Flu (Influenza) Vaccine Product and Services
    Table 36. SINOVAC Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. SINOVAC Recent Developments/Updates
    Table 38. Changsheng Biological Basic Information, Manufacturing Base and Competitors
    Table 39. Changsheng Biological Major Business
    Table 40. Changsheng Biological Flu (Influenza) Vaccine Product and Services
    Table 41. Changsheng Biological Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Changsheng Biological Recent Developments/Updates
    Table 43. SIOBP Basic Information, Manufacturing Base and Competitors
    Table 44. SIOBP Major Business
    Table 45. SIOBP Flu (Influenza) Vaccine Product and Services
    Table 46. SIOBP Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. SIOBP Recent Developments/Updates
    Table 48. GSK Basic Information, Manufacturing Base and Competitors
    Table 49. GSK Major Business
    Table 50. GSK Flu (Influenza) Vaccine Product and Services
    Table 51. GSK Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. GSK Recent Developments/Updates
    Table 53. Aimei Hissen Basic Information, Manufacturing Base and Competitors
    Table 54. Aimei Hissen Major Business
    Table 55. Aimei Hissen Flu (Influenza) Vaccine Product and Services
    Table 56. Aimei Hissen Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Aimei Hissen Recent Developments/Updates
    Table 58. Tianyuan Bio-pharma(Novartis) Basic Information, Manufacturing Base and Competitors
    Table 59. Tianyuan Bio-pharma(Novartis) Major Business
    Table 60. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product and Services
    Table 61. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Tianyuan Bio-pharma(Novartis) Recent Developments/Updates
    Table 63. Simcere Vaxtec Basic Information, Manufacturing Base and Competitors
    Table 64. Simcere Vaxtec Major Business
    Table 65. Simcere Vaxtec Flu (Influenza) Vaccine Product and Services
    Table 66. Simcere Vaxtec Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Simcere Vaxtec Recent Developments/Updates
    Table 68. Global Flu (Influenza) Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 69. Global Flu (Influenza) Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 70. Global Flu (Influenza) Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 71. Market Position of Manufacturers in Flu (Influenza) Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 72. Head Office and Flu (Influenza) Vaccine Production Site of Key Manufacturer
    Table 73. Flu (Influenza) Vaccine Market: Company Product Type Footprint
    Table 74. Flu (Influenza) Vaccine Market: Company Product Application Footprint
    Table 75. Flu (Influenza) Vaccine New Market Entrants and Barriers to Market Entry
    Table 76. Flu (Influenza) Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 77. Global Flu (Influenza) Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 78. Global Flu (Influenza) Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 79. Global Flu (Influenza) Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 80. Global Flu (Influenza) Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 81. Global Flu (Influenza) Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 82. Global Flu (Influenza) Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 83. Global Flu (Influenza) Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 84. Global Flu (Influenza) Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 85. Global Flu (Influenza) Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 86. Global Flu (Influenza) Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 87. Global Flu (Influenza) Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 88. Global Flu (Influenza) Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 89. Global Flu (Influenza) Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 90. Global Flu (Influenza) Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 91. Global Flu (Influenza) Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 92. Global Flu (Influenza) Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 93. Global Flu (Influenza) Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 94. Global Flu (Influenza) Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 95. North America Flu (Influenza) Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 96. North America Flu (Influenza) Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 97. North America Flu (Influenza) Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 98. North America Flu (Influenza) Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 99. North America Flu (Influenza) Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 100. North America Flu (Influenza) Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 101. North America Flu (Influenza) Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 102. North America Flu (Influenza) Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 103. Europe Flu (Influenza) Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 104. Europe Flu (Influenza) Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 105. Europe Flu (Influenza) Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 106. Europe Flu (Influenza) Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 107. Europe Flu (Influenza) Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 108. Europe Flu (Influenza) Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 109. Europe Flu (Influenza) Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 110. Europe Flu (Influenza) Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 111. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 112. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 113. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 114. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 115. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 116. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 117. Asia-Pacific Flu (Influenza) Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 118. Asia-Pacific Flu (Influenza) Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 119. South America Flu (Influenza) Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 120. South America Flu (Influenza) Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 121. South America Flu (Influenza) Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 122. South America Flu (Influenza) Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 123. South America Flu (Influenza) Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 124. South America Flu (Influenza) Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 125. South America Flu (Influenza) Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 126. South America Flu (Influenza) Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 127. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 128. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 129. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 130. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 131. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 132. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 133. Middle East & Africa Flu (Influenza) Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 134. Middle East & Africa Flu (Influenza) Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 135. Flu (Influenza) Vaccine Raw Material
    Table 136. Key Manufacturers of Flu (Influenza) Vaccine Raw Materials
    Table 137. Flu (Influenza) Vaccine Typical Distributors
    Table 138. Flu (Influenza) Vaccine Typical Customers
List of Figures
    Figure 1. Flu (Influenza) Vaccine Picture
    Figure 2. Global Flu (Influenza) Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Flu (Influenza) Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Split Influenza Vaccine Examples
    Figure 5. Pandemic Influenza Vaccine Examples
    Figure 6. Subunit Influenza Vaccine Examples
    Figure 7. Quadrivalent Influenza Vaccine Examples
    Figure 8. Global Flu (Influenza) Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Flu (Influenza) Vaccine Consumption Value Market Share by Application in 2022
    Figure 10. For Children (6 months to 3 years) Examples
    Figure 11. For Adults and Children over 3 years Examples
    Figure 12. Global Flu (Influenza) Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Flu (Influenza) Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Flu (Influenza) Vaccine Sales Quantity (2018-2029) & (K Units)
    Figure 15. Global Flu (Influenza) Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 16. Global Flu (Influenza) Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 17. Global Flu (Influenza) Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 18. Producer Shipments of Flu (Influenza) Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 19. Top 3 Flu (Influenza) Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Top 6 Flu (Influenza) Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Global Flu (Influenza) Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 22. Global Flu (Influenza) Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 23. North America Flu (Influenza) Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Flu (Influenza) Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Flu (Influenza) Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Flu (Influenza) Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East & Africa Flu (Influenza) Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Flu (Influenza) Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 29. Global Flu (Influenza) Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 30. Global Flu (Influenza) Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 31. Global Flu (Influenza) Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 32. Global Flu (Influenza) Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 33. Global Flu (Influenza) Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 34. North America Flu (Influenza) Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 35. North America Flu (Influenza) Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 36. North America Flu (Influenza) Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 37. North America Flu (Influenza) Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Canada Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Mexico Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Europe Flu (Influenza) Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 42. Europe Flu (Influenza) Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 43. Europe Flu (Influenza) Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 44. Europe Flu (Influenza) Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. France Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. United Kingdom Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Russia Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Italy Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 53. Asia-Pacific Flu (Influenza) Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Japan Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Korea Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. India Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Australia Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. South America Flu (Influenza) Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 61. South America Flu (Influenza) Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 62. South America Flu (Influenza) Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 63. South America Flu (Influenza) Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 64. Brazil Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Argentina Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 67. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 68. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 69. Middle East & Africa Flu (Influenza) Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 70. Turkey Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Egypt Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Saudi Arabia Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. South Africa Flu (Influenza) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Flu (Influenza) Vaccine Market Drivers
    Figure 75. Flu (Influenza) Vaccine Market Restraints
    Figure 76. Flu (Influenza) Vaccine Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Flu (Influenza) Vaccine in 2022
    Figure 79. Manufacturing Process Analysis of Flu (Influenza) Vaccine
    Figure 80. Flu (Influenza) Vaccine Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Hualan Bio
CCBIO
Aleph Biomedical
SANOFI
Adimmune
ZYAK
SINOVAC
Changsheng Biological
SIOBP
GSK
Aimei Hissen
Tianyuan Bio-pharma(Novartis)
Simcere Vaxtec

Related Reports

Global Flu (Influenza) Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Flu (Influenza) Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Flu (Influenza) Vaccine market size was valued at USD 5664.4 million in 2023 and is forecast to a readjusted size of USD 7836.7 million by 2030 with a CAGR of 4.7% during review period.

Global Flu (Influenza) Vaccine Supply, Demand and Key Producers, 2024-2030

Global Flu (Influenza) Vaccine Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

The global Flu (Influenza) Vaccine market size is expected to reach $ 7836.7 million by 2030, rising at a market growth of 4.7% CAGR during the forecast period (2024-2030).

Product Tags

Flu (Influenza) Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>